Igor V. Samoylenko;
Lev V. Demidov;
Fedor V. Moiseenko;
Mikhail V. Dvorkin;
Svetlana A. Demidova;
Svetlana A. Protsenko;
Daniil L. Stroyakovskiy;
Vadim V. Kozlov;
Svetlana V. Odintsova;
Dmitry V. Kirtbaya;
Denis A. Tantsyrev;
Anastasia S. Mochalova;
Rashida V. Orlova;
Guzel Z. Mukhametshina;
Natalia V. Fadeeva;
Evgeny A. Fomin;
Yana S. Chapko;
Anna V. Tarasova;
Nikolay B. Ermakov;
Alexander K. Shemerovskiy;
Vera A. Vaschenko;
Valery M. Chistyakov;
Arina V. Zinkina-Orikhan;
Yulia N. Lin'kova;
[...]
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study
Beteiligte:
Igor V. Samoylenko;
Lev V. Demidov;
Fedor V. Moiseenko;
Mikhail V. Dvorkin;
Svetlana A. Demidova;
Svetlana A. Protsenko;
Daniil L. Stroyakovskiy;
Vadim V. Kozlov;
Svetlana V. Odintsova;
Dmitry V. Kirtbaya;
Denis A. Tantsyrev;
Anastasia S. Mochalova;
Rashida V. Orlova;
Guzel Z. Mukhametshina;
Natalia V. Fadeeva;
Evgeny A. Fomin;
Yana S. Chapko;
Anna V. Tarasova;
Nikolay B. Ermakov;
Alexander K. Shemerovskiy;
Vera A. Vaschenko;
Valery M. Chistyakov;
Arina V. Zinkina-Orikhan;
Yulia N. Lin'kova;
[...]